June 23, 2026 Oryn Therapeutics Advances Next Phase of Orynotide™ Macrocyclic Peptide Platform Development with Expanded Leadership Team and Board Anchored by Accomplished Life Sciences Industry Veterans, Company Builders and Drug Developers
June 23, 2026 Remora Releases Its Professional-Grade Options Platform to the Public — and to Any AI Assistant